AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium
Vasileios Sakalis(Agios Pavlos General Hospital), Muhammad Imran Omar(University of Aberdeen), Paweł Rajwa(University College London), Peter-Paul Willemse(European Association of Urology), Saeed Dabestani(Skåne University Hospital), Susan Evans‐Axelsson(Bayer (Germany)), Michael Lardas(National and Kapodistrian University of Athens), Thomas Van den Broeck(KU Leuven), Giorgio Gandaglia(Vita-Salute San Raffaele University), Juan Gómez Rivas(Medico), Katharina Beyer, Alberto Briganti(University College London Hospitals NHS Foundation Trust), Antoni Vilaseca(Hospital Clínic de Barcelona), Benjamin Pradère, Phil Cornford(University of Liverpool), Monique J. Roobol(Erasmus MC), Zafer Tandoğdu, Yagnaseni Bhattacharya(University of Aberdeen), Angelika Borkowetz(Universitätsmedizin Rostock), R. Boissier(Universitat Autònoma de Barcelona), Jeremy Yuen‐Chun Teoh(Chinese University of Hong Kong), Hagen Kruger(Pfizer (Germany)), R. Leenen(Erasmus MC), Steven MacLennan(University of Aberdeen), Gianluca Maresca(NHS Grampian), Charlotte Murray(University of Aberdeen), Emma Jane Smith(European Association of Urology), Marlène Thomas(Roche Pharma AG (Germany)), Natasha Schouten(European Association of Urology), James N’Dow(University of Aberdeen), Anders Bjartell(Lund University)
Cited by 5
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
|European Urology|2020|313
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
|Journal of Clinical Oncology|2020|280